About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Ptgs2
prostaglandin-endoperoxide synthase 2
MGI:97798
202 phenotypes from 14 alleles in 23 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Ptgs2tm1.1Fun/Ptgs2tm1.1Fun
involves: 129S6/SvEvTac 		abnormal kidney cortex morphology J:148699
decreased renal glomerulus number J:148699
glomerulosclerosis J:148699
increased blood urea nitrogen level J:148699
kidney inflammation J:148699
Ptgs2tm1.1Fun/Ptgs2tm1.1Fun
involves: 129S6/SvEvTac * C57BL/6 		abnormal kidney cortex morphology J:109548
abnormal renal glomerulus morphology J:109548
decreased prostaglandin level J:109548
glomerulosclerosis J:109548
pale kidney J:109548
reduced female fertility J:109548
small kidney J:109548
Ptgs2tm1.1Wls/Ptgs2tm1.1Wls
B6.129-Ptgs2tm1.1Wls 		normal cardiovascular system phenotype J:156331
impaired febrile response J:156331
increased susceptibility to endotoxin shock J:156331
increased urine prostaglandin level J:156331
normal renal/urinary system phenotype J:156331
normal reproductive system phenotype J:156331
Ptgs2tm1Fun/Ptgs2tm1Fun
involves: 129S6/SvEvTac * C57BL/6 		abnormal blood coagulation J:108957
abnormal platelet physiology J:108957
abnormal thrombolysis J:108957
decreased prostaglandin level J:109548
decreased susceptibility to induced thrombosis J:108957
decreased urine prostaglandin level J:108957
increased systemic arterial systolic blood pressure J:108957
Ptgs2tm1Gaf/Ptgs2tm1Gaf
A1cfTg(Myh6-cre/Esr1*)1Jmk/?
involves: 129/Sv * C57BL/6 * FVB/N 		decreased heart left ventricle muscle contractility J:148331
decreased heart rate J:148331
dilated heart left ventricle J:148331
impaired exercise endurance J:148331
increased myocardial fiber size J:148331
ventricular tachycardia J:148331
weight loss J:148331
Ptgs2tm1Hahe/Ptgs2tm1Hahe
involves: 129S4/SvJae 		no abnormal phenotype detected J:107615
Ptgs2tm1Jed/Ptgs2tm1Jed
B6;129S-Ptgs2tm1Jed/J 		abnormal stomach pH J:103642
decreased physiological sensitivity to xenobiotic J:103642
pulmonary interstitial fibrosis J:68669
Ptgs2tm1Jed/Ptgs2tm1Jed
involves: 129S7/SvEvBrd 		abnormal kidney collecting duct morphology J:29974
abnormal kidney cortex morphology J:29974
abnormal kidney corticomedullary boundary morphology J:29974
abnormal kidney development J:29974
abnormal kidney mesenchyme morphology J:29974
abnormal kidney morphology J:29974
abnormal renal glomerulus morphology J:29974
abnormal renal tubule morphology J:29974
absent corpus luteum J:29974
cardiac fibrosis J:29974
decreased ovulation rate J:29974
female infertility J:29974
normal hematopoietic system phenotype J:29974
normal immune system phenotype J:29974
increased blood urea nitrogen level J:29974
increased circulating creatinine level J:29974
kidney corticomedullary cyst J:29974
kidney failure J:29974
kidney medulla hypoplasia J:29974
neonatal lethality, incomplete penetrance J:29974
premature death J:29974
pyelonephritis J:29974
small ovary J:29974
Ptgs2tm1Jed/Ptgs2tm1Jed
involves: 129S7/SvEvBrd * C57BL/6 		abnormal decidualization J:43609
abnormal kidney cortex morphology J:104002
abnormal kidney development J:104002
abnormal primary polar body morphology J:43609
abnormal proximal convoluted tubule morphology J:104002
abnormal renal glomerulus morphology J:104002, J:109548, J:118171
normal behavior/neurological phenotype J:104002
normal cardiovascular system phenotype J:104002
cortical renal glomerulopathies J:118171
decreased kidney weight J:104002
decreased litter size J:118171
decreased prostaglandin level J:109548
decreased renal glomerular filtration rate J:104002
decreased superovulation rate J:43609, J:69034
decreased vascular permeability J:118171
dilated renal tubule J:104002
failure of embryo implantation J:43609
glomerulosclerosis J:104002, J:109548
normal growth/size/body region phenotype J:104002
normal homeostasis/metabolism phenotype J:104002
impaired fertilization J:43609
increased blood urea nitrogen level J:104002, J:118171
increased circulating creatinine level J:104002
increased heart weight J:104002
kidney cortex atrophy J:109548
kidney cortex cyst J:104002
kidney cyst J:104002
kidney degeneration J:104002
kidney failure J:104002
pale kidney J:109548
patent ductus arteriosus J:109548
peritoneal inflammation J:118171
premature death J:104002
proximal convoluted tubule brush border loss J:104002
reduced female fertility J:109548, J:118171
renal glomerulus cyst J:104002
renal glomerulus fibrosis J:104002
renal glomerulus hypertrophy J:104002
renal interstitial fibrosis J:104002
renal tubule atrophy J:104002
renal tubule hypertrophy J:104002
normal renal/urinary system phenotype J:104002
normal reproductive system phenotype J:69034
small kidney J:109548
Ptgs2tm1Jed/Ptgs2tm1Jed
involves: 129S7/SvEvBrd * CD-1 		abnormal response to infection J:120725
Ptgs2tm1Unc/Ptgs2+
B6.129P2-Ptgs2tm1Unc 		decreased cerebral infarct size J:67211
decreased prostaglandin level J:67211
Ptgs2tm1Unc/Ptgs2+
D1.129P2(B6J)-Ptgs2tm1Unc 		increased chemical nociceptive threshold J:64383
Ptgs2tm1Unc/Ptgs2+
D1.129P2-Ptgs2tm1Unc 		abnormal adipose tissue physiology J:102779
decreased total fat pad weight J:102779
increased body weight J:102779
increased circulating insulin level J:102779
increased circulating leptin level J:102779
increased prostaglandin level J:102779
increased susceptibility to diet-induced obesity J:102779
Ptgs2tm1Unc/Ptgs2+
involves: 129/Sv * 129P2/OlaHsd * C57BL/6 		abnormal osteoclast differentiation J:124756
decreased prostaglandin level J:124756
Ptgs2tm1Unc/Ptgs2+
involves: 129P2/OlaHsd * C57BL/6J 		impaired febrile response J:54450
increased systemic arterial systolic blood pressure J:155373
Ptgs2tm1Unc/Ptgs2tm1Unc
B6.129P2-Ptgs2tm1Unc 		abnormal choriocapillaris morphology J:281382
abnormal class switch recombination J:140698
abnormal drinking behavior J:125586
abnormal memory B cell differentiation J:140698
abnormal nociception after inflammation J:110716
abnormal response to CNS ischemic injury J:67211
abnormal response to infection J:140698
abnormal response/metabolism to endogenous compounds J:125586
allodynia J:110716
decreased cerebral infarct size J:67211
decreased IgG1 level J:140698
decreased IgG2a level J:140698
decreased IgG3 level J:140698
decreased prostaglandin level J:67211
decreased susceptibility to induced arthritis J:110716
decreased susceptibility to neuronal excitotoxicity J:67211
increased IgM level J:140698
increased thermal nociceptive threshold J:110716
Ptgs2tm1Unc/Ptgs2tm1Unc
B6;129P2-Ptgs2tm1Unc/Tac 		abnormal bone healing J:112346
abnormal endochondral bone ossification J:112346
abnormal inhibitory postsynaptic currents J:141610
abnormal response to injury J:107751
decreased prostaglandin level J:141610
impaired skeletal muscle regeneration J:107751
increased susceptibility to neuronal excitotoxicity J:141610
increased susceptibility to pharmacologically induced seizures J:141610
increased susceptibility to xenobiotic induced morbidity/mortality J:141610
renal glomerulus hypertrophy J:156331
tonic-clonic seizures J:141610
Ptgs2tm1Unc/Ptgs2tm1Unc
D1.129P2(B6J)-Ptgs2tm1Unc 		abnormal kidney mesenchyme morphology J:102777
abnormal kidney morphology J:64383
abnormal renal glomerulus morphology J:102777
normal behavior/neurological phenotype J:64383
decreased aggression J:64383
decreased hematocrit J:102777
decreased kidney weight J:102777
female infertility J:64383
granular kidney J:102777
increased blood urea nitrogen level J:102777
increased circulating creatinine level J:102777
normal mortality/aging J:64383
pale kidney J:102777
postnatal lethality J:102777
renal glomerulus cyst J:102777
renal glomerulus hypertrophy J:102777
renal interstitial fibrosis J:102777
small kidney J:102777
Ptgs2tm1Unc/Ptgs2tm1Unc
D1.129P2-Ptgs2tm1Unc 		decreased prostaglandin level J:102779
Ptgs2tm1Unc/Ptgs2tm1Unc
involves: 129/Sv * 129P2/OlaHsd * C57BL/6 		abnormal osteoclast differentiation J:124756
decreased platelet calcium level J:124756
decreased prostaglandin level J:124756
Ptgs2tm1Unc/Ptgs2tm1Unc
involves: 129P2/OlaHsd 		normal digestive/alimentary phenotype J:108679
Ptgs2tm1Unc/Ptgs2tm1Unc
involves: 129P2/OlaHsd * C57BL/6 		abnormal colon morphology J:60668
abnormal enzyme/coenzyme level J:108054
abnormal keratinocyte differentiation J:117986
abnormal kidney cortex morphology J:104002
abnormal kidney development J:104002
abnormal proximal convoluted tubule morphology J:104002
abnormal renal glomerulus morphology J:104002
abnormal response of heart to induced stress J:103388
anemia J:60668
normal behavior/neurological phenotype J:104002
normal cardiovascular system phenotype J:104002
decreased hematocrit J:60668
decreased incidence of tumors by chemical induction J:158426
decreased kidney weight J:104002
decreased lactate dehydrogenase level J:108054
decreased prostaglandin level J:60668, J:117986
decreased renal glomerular filtration rate J:104002
decreased susceptibility to endotoxin shock J:75611
decreased susceptibility to induced pancreatitis J:108054
decreased susceptibility to injury J:108054
dilated renal tubule J:104002
enlarged spleen J:60668
glomerulosclerosis J:104002
normal growth/size/body region phenotype J:104002
normal homeostasis/metabolism phenotype J:104002
increased blood urea nitrogen level J:104002
increased circulating creatinine level J:104002
increased heart weight J:104002
increased incidence of induced tumors J:158426
increased leukocyte cell number J:60668
increased susceptibility to induced colitis J:60668, J:158426
increased susceptibility to xenobiotic induced morbidity/mortality J:60668, J:158426
increased tumor necrosis factor secretion J:108054
kidney cortex cyst J:104002
kidney cyst J:104002
kidney degeneration J:104002
kidney failure J:104002
normal muscle phenotype J:146321
pancreas necrosis J:108054
peritoneal inflammation J:60668
premature death J:104002
proximal convoluted tubule brush border loss J:104002
renal glomerulus cyst J:104002
renal glomerulus fibrosis J:104002
renal glomerulus hypertrophy J:104002
renal interstitial fibrosis J:104002
renal tubule atrophy J:104002
renal tubule hypertrophy J:104002
normal renal/urinary system phenotype J:104002
weight loss J:60668
Ptgs2tm1Unc/Ptgs2tm1Unc
involves: 129P2/OlaHsd * C57BL/6 * DBA/1 		abnormal wound healing J:126734
Ptgs2tm1Unc/Ptgs2tm1Unc
involves: 129P2/OlaHsd * C57BL/6J 		abnormal corpus luteum morphology J:55145
abnormal cumulus expansion J:55145
abnormal induced retina neovascularization J:109021
abnormal intestinal mucosa morphology J:29510
abnormal kidney capsule morphology J:29510
abnormal kidney development J:29510
abnormal kidney morphology J:29510
abnormal kidney papilla morphology J:29510
abnormal lipid homeostasis J:121680
abnormal liver morphology J:67208
abnormal macrophage physiology J:29510
abnormal mesenteric lymph node morphology J:29510
abnormal nephrogenic zone morphology J:29510
abnormal reproductive system physiology J:29510
abnormal thrombosis J:109021
decreased nephron number J:29510
decreased prostaglandin level J:55145, J:109021
decreased renal glomerulus number J:29510
decreased superovulation rate J:55145
decreased survivor rate J:67208
dilated renal tubule J:29510
failure of superovulation J:55145
female infertility J:55145
glomerulosclerosis J:29510
normal homeostasis/metabolism phenotype J:55145
normal immune system phenotype J:29510
impaired febrile response J:54450
impaired granulosa cell differentiation J:55145
increased circulating follicle stimulating hormone level J:55145
increased circulating luteinizing hormone level J:55145
increased systemic arterial blood pressure J:155373
increased systemic arterial diastolic blood pressure J:155373
increased systemic arterial systolic blood pressure J:155373
intestinal edema J:29510
kidney cortex atrophy J:29510
neonatal lethality, incomplete penetrance J:67208
nephrocalcinosis J:29510
pale kidney J:29510, J:55145
patent ductus arteriosus J:67208
peritoneal inflammation J:29510
postnatal lethality, incomplete penetrance J:67208
premature death J:29510
renal cast J:29510
renal glomerulus hypertrophy J:29510
renal interstitial fibrosis J:29510
renal tubule atrophy J:29510
small kidney J:29510
spleen hyperplasia J:29510
tubulointerstitial nephritis J:29510
Ptgs2tm1Unc/Ptgs2tm2.1Hahe
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 		increased susceptibility to induced colitis J:158426
increased susceptibility to xenobiotic induced morbidity/mortality J:158426
normal neoplasm J:158426
Ptgs2tm1Wlf/Ptgs2tm1Wlf
Tg(Nes-cre)1Kln/0
involves: C57BL/6 * SJL 		abnormal chemical nociception J:146193
abnormal nociception after inflammation J:146193
normal homeostasis/metabolism phenotype J:146193
Ptgs2tm3Fun/Ptgs2tm3Fun
involves: 129S6/SvEvTac * C57BL/6J 		abnormal renal glomerulus morphology J:148699
abnormal renal tubule morphology J:148699
abnormal urine homeostasis J:148699
normal cardiovascular system phenotype J:148699
increased blood urea nitrogen level J:148699
increased platelet aggregation J:148699
increased susceptibility to induced thrombosis J:148699
normal renal/urinary system phenotype J:148699
Tg(K5-Ptgs2)19Kmd/0
involves: NMRI 		abnormal coat appearance J:70039
abnormal dermal layer morphology J:70039
abnormal hair follicle development J:70039
abnormal hair follicle orientation J:70039
abnormal nail morphology J:70039
alopecia J:70039
coarse hair J:70039
decreased hair follicle number J:70039
epidermal hyperplasia J:70039
greasy coat J:70039
hyperkeratosis J:70039
increased incidence of tumors by chemical induction J:79071
increased prostaglandin level J:70039
increased sebaceous gland adenoma incidence J:79071
increased skin papilloma incidence J:79071
increased squamous cell carcinoma incidence J:79071
long toenails J:70039
sebaceous gland hyperplasia J:70039
sparse hair J:70039
thin skin J:70039
Tg(K5-Ptgs2)667Kmd/0
involves: NMRI 		abnormal coat appearance J:70039
abnormal coat/ hair morphology J:70039
abnormal dermal layer morphology J:70039
abnormal hair follicle development J:70039
abnormal hair follicle orientation J:70039
abnormal nail morphology J:70039
alopecia J:70039
coarse hair J:70039
decreased hair follicle number J:70039
epidermal hyperplasia J:70039
hyperkeratosis J:70039
increased incidence of tumors by chemical induction J:79071
increased prostaglandin level J:70039
increased sebaceous gland adenoma incidence J:79071
increased skin papilloma incidence J:79071
increased squamous cell carcinoma incidence J:79071
long toenails J:70039
premature death J:79071
sebaceous gland hyperplasia J:70039
sparse hair J:70039
thin skin J:70039
Tg(K5-Ptgs2)675Kmd/0
involves: NMRI 		abnormal coat appearance J:70039
abnormal coat/ hair morphology J:70039
abnormal dermal layer morphology J:70039
abnormal hair follicle development J:70039
abnormal hair follicle orientation J:70039
abnormal nail morphology J:70039
alopecia J:70039
coarse hair J:70039
decreased hair follicle number J:70039
epidermal hyperplasia J:70039
greasy coat J:70039
hyperkeratosis J:70039
increased prostaglandin level J:70039
long toenails J:70039
premature death J:70039
sebaceous gland hyperplasia J:70039
sparse hair J:70039
thin skin J:70039
Tg(K5-Ptgs2)675Kmd/Tg(K5-Ptgs2)675Kmd
involves: NMRI 		abnormal hair cycle J:85979
abnormal hair follicle morphology J:85979
alopecia J:85979
sebaceous gland hyperplasia J:85979
sparse hair J:85979
Tg(Nphs1-Ptgs2)14Rhrs/0
involves: C57BL/6 * DBA/2 		abnormal glomerular mesangium morphology J:148158, J:179350
abnormal podocyte morphology J:179350
albuminuria J:148158, J:179350
increased renal glomerulus basement membrane thickness J:179350
increased susceptibility to injury J:148158
podocyte foot process effacement J:148158, J:179350
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory